Centene's Medicaid Handbrake Finally Lets Go — But $0.50 of the Beat Won't Repeat

Guidance jumps to >$5.20 from >$4.80 on a 30bp Medicaid HBR gain and a Medicare Advantage breakeven a year early — while the CFO quietly moves the 2027 starting line back to $4.70.

CNC · Earnings Call · 2026-10-27

The Beat Is Real. The Base Isn't.

Centene did what it had promised for six quarters: it bent the Medicaid cost curve. Third-quarter adjusted diluted EPS of $0.58 ran ahead of plan, the consolidated HBR of 92.7% beat internal expectations, Medicaid came in at 93.6% — a 30 basis point sequential improvement — and full-year adjusted EPS guidance moved to more than $5.20 from more than $4.80. Medicare Advantage is now tracking to breakeven in 2026, a full year ahead of the multiyear plan. On the surface, a clean margin-restoration print. Then Drew Asher took it apart himself. Of that $5.20, $0.50 is non-recurring — $180 million in Marketplace and $160 million largely in PDP — and he told the room the honest starting point for next year is lower: “we expect to grow adjusted EPS relative to not only the $4.70 jump off, but also relative to our revised $5.20 2026 adjusted EPS guidance.” — Andrew Lynn Asher, Executive Vice President and Chief Financial Officer · 2026-10-27 Growing off both bases is a big promise. Growing off the lower one is table stakes. The gap between them — $0.50, roughly a tenth of the base — is exactly the size of the cushion management has just spent.

The Tell That Disappeared

For four consecutive calls, Sarah London carried a verbal tic. February: “If all we do is deliver a 93.7 in Medicaid, I will be very disappointed.” April: “I would be disappointed if we didn't beat 93.7% given where we stand today, I will reiterate that I will be disappointed if that's all we can do.” — Sarah London, Chief Executive Officer · 2026-04-28 July: the same sentiment, again, attached to a promise that the goal remained margin recovery “even through the OB3 headwinds over the next year or 2.” That phrase is gone from the Q3 transcript. What replaced it is the substance the hedge was standing in for: a quantified HBR path, a raised EPS floor, and a claim that core trend has genuinely turned. London pointed to a third consecutive quarter of year-over-year moderation in behavioral health, with home health now following the same shape — “On a positive note, we observed another quarter of year over year stabilization in behavioral health trend with a similar pattern beginning to emerge in home health.” — Sarah London, Chief Executive Officer · 2026-10-27 The acuity impact story and the HBR improvement story have flipped polarity: the first was a threat, now it is the thing being managed into rate. That is the mechanical heart of the quarter. In July, the team was explicitly holding back 50 basis points of rate favorability to see how back-half membership attrition would bite. In October, most of that reserve was spent: “we saw some of that acuity shift and some of that utilization in Q3 matched up against that chewed up some of the 50 basis points...” — Sarah London, Chief Executive Officer · 2026-10-27 — with the remainder deliberately warehoused for Q4, when the 8%–9% full-year membership decline does its heaviest work. It is a rare case of a reserve being drawn and the guidance still going up.

I think everybody is right to be focused on the potential for a dislocation between rate and acuity. But I would say where we stand today, there are more positive signals than negative probably for the first time in a long while.
Sarah London, Chief Executive Officer · 2026-10-27

Consider what that reframes. The dislocation between rate and acuity — a ranked theme this quarter — has been the central fear since redeterminations. London's new argument is that 2026 itself is absorbing the work-requirement shock ahead of schedule, that states are writing explicit prospective provisions into draft rates, and that CMS is encouraging mid-cycle true-ups. If true, the expansion population headwind that dominated the July call is a smaller 2027 problem than the tape assumes. If it is not true, the same sentence is what every Medicaid plan says before a bad rate cycle.

Two Turnarounds, Two Different Grades

Medicare and Marketplace both produced the numbers, but not the same quality of number. PDP pretax margin moved to the mid-to-high 3s from “more than 3%” in July, and Marketplace lands at the top of its 4.5%–5.0% range — “marketplace 1.0% pretax margin last year as we talked about in 2025 to a now 5.0% forecasted pretax margin” — Andrew Lynn Asher, Executive Vice President and Chief Financial Officer · 2026-10-27, a 600 basis point round trip in twelve months. Asher was careful to say the IDR and program-integrity reserving that helped fund the quarter will not recur in Q4. And PDP, the biggest single contributor to the raise, is being pre-announced downward for 2027: an opening expectation of 2%–3%. That is a headwind the guidance slide does not bury but does soften. Less visible is a portfolio subtraction disclosed only under questioning — the exit from the Health Net commercial group business, largely California, roughly $4 billion of revenue, unwound over 18–24 months. It never appears in prepared remarks. Meanwhile unauthorized enrollment and broker fraud have entered the company's top keyword ranks for the first time as a structural cost of the ACA business, alongside auto assign membership in Part D. The peer read confirms this is not a Centene-only inflection. Molina, reporting the same week, led with Medicaid margins, a Florida CMS program transition that also lands on Centene's October 1 roll-off, and its own version of core-trend stabilization. Sector signal, not company secret — which cuts both ways.

What The Tape Already Paid For

The stock entered this print leaning forward: +7.9% over ninety days, closing on October 27 within 3.6% of a 90-day high of $71.24 set on October 22. Yet it remains roughly 29% below the August 2022 peak of $97.22, and the whole-history shape is a recovery, not a breakout. The fundamentals explain both halves. Total revenue is running at a $53.6 billion quarterly clip, up 10% year over year. Operating income swung from a $6.95 billion loss in 2025Q3 to positive $1.49 billion by 2026Q2 — the entire equity story in one series. And effective net cash has rebuilt to $11.1 billion, helped by $15.0 billion of total debt versus $18.5 billion at the end of 2024. At 13x trailing net income, the market is not paying for perfection. But it is paying for delivery on a 2027 plan that must absorb a January 1 start to work requirements, the California immigration-status population removal, a PDP margin reset, and a Marketplace management expects to contract slightly — while still growing off a $4.70 base. The most underrated line on the call was not financial at all: D-SNP members with richer healthy-food benefits showing roughly $200 per member per month in lower claims. That is where the durable margin is supposed to come from. Everything above it is rate mechanics.